![ecancer](http://media.vumedi.com/thumbs/channel_logo/2020/8/0bffd421-174a-4418-b45d-1b6192c3c1d9.png.200x0_q85.png)
ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
- ELCC 2024
- EAU 2024
- ASCO GU 2024
- ASCO GI 2024
- AORTIC 2023
- ASH 2023
- SABCS 2023
- ESMO 2023
- Common Sense Oncology
- WCLC 2023
- ESMO WCGIC 2023
- ASCO® 2023
- EHA® 2023
- ELCC 2023
- ASCO GU 2023
- BGICC 2023
- ASCO GI 2023
- SABCS 2022
- ESMO 2022
- WCLC 2022
- EHA 2022
- ASCO 2022
- ASCO 2021
- Lymphoma
- Leukemia
- Myeloma
- GYN Cancers
- Head&Neck Cancers
- GI Cancers
- Breast Cancers
- GU Cancers
- Lung Cancers
- Skin Cancers
- Basic Science
- Supportive & Palliative Care
- Business
- Events
Playback speed
10 seconds
2020 ASCO Updates on Bladder Cancer: Should We Give IO in the Maintenance Setting or 2L at Progression? How Effective Are FGFRi? Can FGFR mRNA Over-Expression Help Identify Pts Who Can Benefit From Targeted Therapy?
121 views
November 16, 2020
Login to view comments.
Click here to Login
GU Cancers